Tumor inhibition and effects on host survival time by rutheniumIII and rhodiumIII complexes with dimethylsulphoxide ligands

Pharmacol Res. 1992 Feb-Mar:25 Suppl 1:73-4. doi: 10.1016/1043-6618(92)90546-n.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Mice
  • Organometallic Compounds / therapeutic use*
  • Rhodium / therapeutic use*
  • Ruthenium / therapeutic use*

Substances

  • Antineoplastic Agents
  • Organometallic Compounds
  • Ruthenium
  • Rhodium